Patents by Inventor Pu-Ping Lu

Pu-Ping Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds, compositions, and methods
    Patent number: 7041676
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: May 9, 2006
    Assignees: Cytokinetics, Inc., Smithkline Beecham Corporation
    Inventors: Andrew McDonald, Pu-Ping Lu, Gustave Bergnes, David J. Morgans, Jr., Dashyant Dhanak, Steven David Knight
  • 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
    Patent number: 7038048
    Abstract: Provided herein are certain compounds of Formula I: that can be used to treat diseases of proliferating cells. The compounds are KSP kinesin inhibitors, particularly inhibitors of human KSP.
    Type: Grant
    Filed: May 22, 2003
    Date of Patent: May 2, 2006
    Assignees: Cytokinetics, Inc., SmithKline Beecham Corporation
    Inventors: Pu-Ping Lu, David J. Morgans, Jr., Bing Yao, Dashyant Dhanak, Steven David Knight
  • Compounds, compositions, and methods
    Publication number: 20060019988
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: July 21, 2005
    Publication date: January 26, 2006
    Inventors: Andrew McDonald, Pu-Ping Lu, Gustave Bergnes, David Morgans, Dashyant Dhanak, Steven Knight
  • Compounds, compositions and methods
    Publication number: 20060014761
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: June 16, 2005
    Publication date: January 19, 2006
    Inventors: Bradley Morgan, Alex Muci, Pu-Ping Lu, Erica Kraynack, Todd Tochimoto, David Morgans
  • Compounds, compositions and methods
    Publication number: 20050159416
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: July 14, 2004
    Publication date: July 21, 2005
    Inventors: Bradley Morgan, Kathleen Elias, Erica Kraynack, Pu-Ping Lu, Fady Malik, Alex Muci, Xiangping Qian, Whitney Smith, Todd Tochimoto, Adam Tomasi, David Morgans
  • Compositions and methods for treating heart failure
    Publication number: 20050148638
    Abstract: Certain substituted benzamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: January 20, 2005
    Publication date: July 7, 2005
    Applicant: Cytokinetics, Inc.
    Inventors: Fady Malik, Adam Tomasi, Bainian Feng, Erica Kraynack, Kathleen Elias, Pu-Ping Lu, Whitney Smith, Xiangping Qian, David Morgans
  • Compositions and methods for treating heart failure
    Patent number: 6908923
    Abstract: Certain substituted benzamide derivatives of Formula I: selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: June 21, 2005
    Assignee: Cytokinetics, Inc.
    Inventors: Fady Malik, Adam Lewis Tomasi, Bainian Feng, Erica Anne Kraynack, Kathleen A. Elias, Pu-Ping Lu, Whitney Walter Smith, Xiangping Qian, David J. Morgans, Jr.
  • Compounds, compositions, and methods
    Publication number: 20040116438
    Abstract: Compounds, compositions and methods useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: May 22, 2003
    Publication date: June 17, 2004
    Inventors: Pu-Ping Lu, David J. Morgans, Bing Yao, Dashyant Dhanak, Steven David Knight
  • Compounds, compositions, and methods
    Publication number: 20040082567
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: June 12, 2003
    Publication date: April 29, 2004
    Applicants: Cytokinetics, Inc., Smithkline Beecham Corporation
    Inventors: Andrew McDonald, Pu-Ping Lu, Gustave Bergnes, David J. Morgans, Dashyant Dhanak, Steven David Knight
  • Compositions and methods for treating heart failure
    Publication number: 20030158233
    Abstract: Certain substituted benzamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: December 20, 2002
    Publication date: August 21, 2003
    Inventors: Fady Malik, Adam Lewis Tomasi, Bainian Feng, Erica Anne Kraynack, Kathleen A. Elias, Pu-Ping Lu, Whitney Walter Smith, Xiangping Qian, David J. Morgans,
  • Compositions and methods for treating heart failure
    Publication number: 20030158186
    Abstract: Certain substituted benzamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: December 20, 2002
    Publication date: August 21, 2003
    Inventors: Fady Malik, Adam Lewis Tomasi, Bainian Feng, Bradley Paul Morgan, Han-Jie Zhou, Kathleen A. Elias, Pu-Ping Lu, Whitney Walter Smith, Xiangping Qian, David J. Morgans,